ProCE Banner Activity

Integrating the Latest Treatments for T2D Into Patient Care: Connecting Mechanism of Action to Physiologic Actions


Download this slideset discussing the mechanisms of action of SGLT2 inhibitors, GLP-1 receptor agonists, and GIP/GLP-1 coagonists and how these mechanisms benefit patients with type 2 diabetes and obesity.

Released: November 15, 2023



Vivian A. Fonseca

Vivian A. Fonseca, MD, FRCP

Professor of Medicine and Pharmacology
Assistant Dean for Clinical Research
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences center
New Orleans, Louisiana

Jennifer B. Green

Jennifer B. Green, MD

Professor of Medicine
Division of Endocrinology
Department of Medicine
Duke Clinical Research Institute
Duke University Medical Center
Durham, North Carolina

Carol Hatch Wysham

Carol Hatch Wysham, MD

Clinical Professor of Medicine
Clinical Endocrinologist
MultiCare/Rockwood Clinic
Spokane, Washington

Provided by

Provided by Clinical Care Options, LLC in partnership with Endocrine Society.

ProCE Banner


Supported by an educational grant from Lilly.



Endocrine Society

ProCE Banner